Resultaten visas 1 - 10 / 1013
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År
Publicationer information ikon

Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice

Referentgranskad
Öppen tillgång
DOI
10.1080/21645515.2021.1953346
ZOE-SCT Study Grp Collaborators; Stadtmauer, Edward A.; Sullivan, Keith M.; El Idrissi, Mohamed; Sal...
Human vaccines & immunotherapeutics2021Publicationer information ikon

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation : A Randomized Clinical Trial

Referentgranskad
Öppen tillgång
DOI
10.1001/jama.2019.9053
Adriana Bastidas, Javier de la Serna, Mohamed El Idrissi, Lidia Oostvogels, Philippe Quittet, Javier...
JAMA : Journal of the American Medical Association2019Publicationer information ikon

Immunogenicity and safety of the non-typable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone:Results from a randomized, phase 2a, non-inferiority trial

Referentgranskad
Öppen tillgång
DOI
10.1080/21645515.2023.2187194
Galgani, Ilaria; Poder, Airi; Jogi, Rain; Anttila, Veli-Jukka; Milleri, Stefano; Borobia, Alberto M....
Human vaccines & immunotherapeutics2023Publicationer information ikon

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant:A phase 3, randomized clinical trial

Referentgranskad
Öppen tillgång
DOI
10.1093/cid/ciz177
Vink, P.; Torrell, J.M.R.; Fructuoso, A.S.; Kim, Sung-Joo; Kim, Sang-Il; Zaltzman, J.; Ortiz, F.; Pl...
Clinical infectious diseases2020Publicationer information ikon

Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

Referentgranskad
Öppen tillgång
DOI
10.1016/j.vaccine.2019.03.043
López-Fauqued, M.;McElhaney, J.E.;McNeil, S.A.;Yeo, W.;Tavares-Da-Silva, F.;Ahonen, A.;Avelino-Silva...
VACCINE2019Publicationer information ikon

Quality of life impact of an adjuvanted recombinant zoster vaccine in adults aged 50 years and older

Referentgranskad
Öppen tillgång
DOI
10.1093/gerona/gly150
Curran, Desmond;Athan, Eugene;Berglund, Johan;Campora, Laura;de Looze, Ferdinandus;Korhonen, Tiina;L...
JOURNALS OF GERONTOLOGY SERIES A: BIOLOGICAL SCIENCES AND MEDICAL SCIENCES2018Publicationer information ikon

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

Referentgranskad
Öppen tillgång
DOI
10.1093/infdis/jiy095
Cunningham, AL;Choi, WS;Esen, M;Ikematsu, H;Choma, MK;Pauksens, K;Ravault, S;Salaun, B;Schwarz, TF;S...
JOURNAL OF INFECTIOUS DISEASES2018Publicationer information ikon

Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine.

Referentgranskad
Levin Myron J; Schmader Kenneth E; Gnann John W; McNeil Shelly A; Vesikari Timo; Betts Robert F; Kea...
Journal of infectious diseases2013Publicationer information ikon

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

Referentgranskad
Öppen tillgång
DOI
10.1093/cid/ciab629
Boutry, Céline; Hastie, Andrew; Diez-Domingo, Javier; Tinoco, Juan Carlos; Yu, Chong Jen; Andrews, C...
CLINICAL INFECTIOUS DISEASES2022Publicationer information ikon

Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults

Referentgranskad
Öppen tillgång
DOI
10.1056/NEJMoa1501184
Lal, Himal;Puig-Barberà, Joan;Vesikari, Timo;Watanabe, Daisuke;Weckx, Lily;Zahaf, Toufik;Heineman, T...
NEW ENGLAND JOURNAL OF MEDICINE2015

Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice

Referentgranskad
Öppen tillgång
DOI
10.1080/21645515.2021.1953346
2021

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation : A Randomized Clinical Trial

Referentgranskad
Öppen tillgång
DOI
10.1001/jama.2019.9053
2019

Immunogenicity and safety of the non-typable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone:Results from a randomized, phase 2a, non-inferiority trial

Referentgranskad
Öppen tillgång
DOI
10.1080/21645515.2023.2187194
2023

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant:A phase 3, randomized clinical trial

Referentgranskad
Öppen tillgång
DOI
10.1093/cid/ciz177
2020

Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

Referentgranskad
Öppen tillgång
DOI
10.1016/j.vaccine.2019.03.043
2019

Quality of life impact of an adjuvanted recombinant zoster vaccine in adults aged 50 years and older

Referentgranskad
Öppen tillgång
DOI
10.1093/gerona/gly150
2018

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

Referentgranskad
Öppen tillgång
DOI
10.1093/infdis/jiy095
2018

Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine.

Referentgranskad
2013

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

Referentgranskad
Öppen tillgång
DOI
10.1093/cid/ciab629
2022

Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults

Referentgranskad
Öppen tillgång
DOI
10.1056/NEJMoa1501184
2015